Gopal Bajaj is a Radiation Oncologist in Falls Church, Virginia. Dr. Bajaj is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Breast Cancer, Metastatic Brain Tumor, and Gastrostomy. Dr. Bajaj is currently accepting new patients.

Avani Rao is a Radiation Oncologist in Fairfax, Virginia. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Familial Prostate Cancer. Dr. Rao is currently accepting new patients.

Patty Lee is an Otolaryngologist in Reston, Virginia. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Tongue Cancer, Adenoid Cystic Carcinoma, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Thyroidectomy.

Todd Spock is an Otolaryngologist in Fairfax, Virginia. Dr. Spock is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Sinusitis, Empyema, Allergic Rhinitis, Endoscopy, and Septoplasty. Dr. Spock is currently accepting new patients.

Jacob Kuperstock is an Otolaryngologist and a Plastic Surgeon in Fairfax, Virginia. Dr. Kuperstock is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Infant Hearing Loss. Dr. Kuperstock is currently accepting new patients.

Lonika Majithia is a Radiation Oncologist in Falls Church, Virginia. Dr. Majithia is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Breast Cancer, Metastatic Brain Tumor, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix. Dr. Majithia is currently accepting new patients.

Tobias Chapman is a Radiation Oncologist in Falls Church, Virginia. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor. Dr. Chapman is currently accepting new patients.

Joshua Thompson is an Otolaryngologist in Falls Church, Virginia. Dr. Thompson is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Tongue Cancer, Nasal Septal Hematoma, Low Nasal Bridge, Empyema, and Glossectomy. Dr. Thompson is currently accepting new patients.

Mark Domanski is a Plastic Surgeon and an Otolaryngologist in Fairfax, Virginia. Dr. Domanski is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Tongue Cancer, Breast Enlargement In Males, Oral Squamous Cell Carcinoma, and Tissue Biopsy.

Christopher Johnson is a Radiation Oncologist in Fairfax, Virginia. Dr. Johnson has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Metastatic Brain Tumor, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Johnson is currently accepting new patients.

Mustafa Abugideiri is a Radiation Oncologist in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Abugideiri is currently accepting new patients.

John Deeken is an Oncologist and a Hematologist Oncology provider in Fairfax, Virginia. Dr. Deeken is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Oral Squamous Cell Carcinoma. Dr. Deeken is currently accepting new patients.

Daniel Kim is a Radiation Oncologist in Fairfax, Virginia. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Brain Tumor, and Prostatectomy. Dr. Kim is currently accepting new patients.

Sarah Gao is a Radiologist and a Radiation Oncologist in Fairfax, Virginia. Dr. Gao is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Familial Prostate Cancer, Prostate Cancer, and Lymphadenectomy. Dr. Gao is currently accepting new patients.

Stella Hetelekidis is a Radiation Oncologist in Fairfax, Virginia. Dr. Hetelekidis is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Breast Cancer, Endometrial Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer. Dr. Hetelekidis is currently accepting new patients.

Timothy Egan is an Otolaryngologist in Falls Church, Virginia. Dr. Egan is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Tinnitus, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Obstructive Sleep Apnea, and Sinusitis. Dr. Egan is currently accepting new patients.

Ingrid Schneider is a Radiologist and an Interventional Radiologist in Fairfax, Virginia. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Thyroid Nodule, Mikulicz Disease, and Lymphofollicular Hyperplasia. Dr. Schneider is currently accepting new patients.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.